Verition Fund Management »

Vaneck Vectors Pharmaceutical etf shares owned by Verition Fund Management

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $505k 4.9k 103.17
2025-09-30 $1.9M 21k 90.36
2025-06-30 $356k 4.0k 87.96
2025-03-31 $461k 5.1k 91.13
2024-12-31 $349k 4.0k 86.28

More positions owned by Verition Fund Management

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Warner Bros Discovery Com Ser A (WBD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Electronic Arts (EA)
Ishares Tr Russell 2000 Etf (IWM)
Palantir Technologies Cl A (PLTR)
Micron Technology (MU)

View all positions for Verition Fund Management

Top funds holding Vaneck Vectors Pharmaceutical etf

Healthcare Of Ontario Pension Plan Trust Fund
Goldman Sachs Group
British Columbia Investment Management Corporation
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Bnp Paribas Arbitrage, Snc
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Adamsbrown Wealth Consultants
Susquehanna International
UBS Group
LPL Financial

View all funds holding Vaneck Vectors Pharmaceutical etf